REAL-WORLD TREATMENT PATTERNS AND VISUAL OUTCOMES IN THE FIRST 12 MONTHS OF FARICIMAB USE IN DME: UK FARWIDE-DME STUDY

被引：0
|
作者：
Kiire, C. [1 ,10 ,11 ]
Peto, T. [2 ,3 ]
Reynolds, R. R. [4 ,5 ]
Bailey, C. B. [6 ]
Downey, L. D. [7 ]
Pearce, I. P. [8 ]
Sivaprasad, S. S. [9 ]
James, N. J. [10 ]
Shah, N. S. [10 ]
Dayal, P. D. [11 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England
[2] Queens Univ Belfast, Belfast, Antrim, North Ireland
[3] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland
[4] Aneurin Bevan Univ Hlth Board, Cardiff, Wales
[5] Cardiff Univ, Sch Vision Sci, Cardiff, Wales
[6] Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England
[7] Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[8] Liverpool Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
[9] Moorfields Eye Hosp NHS Fdn Trust, London, England
[10] Roche Prod Ltd, Welwyn Garden City, Herts, England
[11] Genentech Inc, San Francisco, CA USA
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2024年 / 34卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：34 / 35
页数：2
相关论文
共 50 条
  • [1] Real-World Use of Off-Label MVASI in the Treatment of Patients With Neovascular AMD and DME
    Lombardo, Marco
    Missiroli, Filippo
    Cerri, Luca
    Sorge, Roberto P.
    Cesareo, Massimo
    Ricci, Federico
    [J]. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2024, 13 (07):
  • [2] Good real-world outcomes in DME patients with poor baseline visual acuity at I year: results from LUMINOUS™
    Mitchell, Paul
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [3] Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME)
    Giancipoli, Ermete
    Guglielmi, Antonella
    Bux, Anna Valeria
    Clima, Giulia Maria Emilia
    Pignatelli, Francesco
    Boscia, Francesco
    Viggiano, Pasquale
    Boscia, Giacomo
    Fortunato, Francesca
    Besozzi, Gianluca
    Niro, Alfredo
    Dore, Stefano
    Iaculli, Cristiana
    [J]. OPHTHALMOLOGY AND THERAPY, 2024, : 2163 - 2184
  • [4] Efficacy of intravitreal avastin for the treatment of centre involving diabetic maculopathy in a real-world setting (Auckland DME study II)
    Sadeghi, Sepehr
    Al-Ani, Haya Husam
    Hill, Sophie
    Alsheikhi, Moaz
    Vaghefi, Ehsan
    Squirrell, David
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 : 147 - 147
  • [5] Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study
    Garcher, Catherine P. Creuzot
    Massin, Pascale
    Kodjikian, Laurent
    Girmens, Jean-Francois
    DelCourt, Cecile
    Fajnkuchen, Frank
    Glacet, Agnes
    Guillausseau, Pierre-Jean
    Derveloy, Audrey
    Finzi, Laetitia
    Blin, Patrick
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [6] Real-World Outcomes after 36-Month Treatment with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema (BOREAL-DME)
    Massin, Pascale
    Creuzot-Garcher, Catherine
    Kodjikian, Laurent
    Girmens, Jean-Francois
    Delcourt, Cecile
    Fajnkuchen, Franck
    Glacet-Bernard, Agnes
    Guillausseau, Pierre-Jean
    Guthux, Francoise
    Blin, Patrick
    Grelaud, Angela
    [J]. OPHTHALMIC RESEARCH, 2021, 64 (04) : 577 - 586
  • [7] Real-world management of treatment-naive diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study
    Shimura, Masahiko
    Kitano, Shigehiko
    Muramatsu, Daisuke
    Fukushima, Harumi
    Takamura, Yoshihiro
    Matsumoto, Makiko
    Kokado, Masahide
    Kogo, Jiro
    Sasaki, Mariko
    Morizane, Yuki
    Kotake, Osamu
    Koto, Takashi
    Sonoda, Shozo
    Hirano, Takao
    Ishikawa, Hiroto
    Mitamura, Yoshinori
    Okamoto, Fumiki
    Kinoshita, Takamasa
    Kimura, Kazuhiro
    Sugimoto, Masahiko
    Yamashiro, Kenji
    Suzuki, Yukihiko
    Hikichi, Taiichi
    Washio, Noriaki
    Sato, Tomohito
    Ohkoshi, Kishiko
    Tsujinaka, Hiroki
    Kusuhara, Sentaro
    Kondo, Mineo
    Takagi, Hitoshi
    Murata, Toshinori
    Sakamoto, Taiji
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2020, 104 (09) : 1209 - 1215
  • [8] Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME Study
    Massin, Pascale
    Creuzot-Garcher, Catherine
    Kodjikian, Laurent
    Girmens, Jean-Francois
    Delcourt, Cecile
    Fajnkuchen, Frank
    Glacet-Bernard, Agnes
    Guillausseau, Pierre-Jean
    Ponthieux, Anne
    Blin, Patrick
    Grelaud, Angela
    [J]. OPHTHALMIC RESEARCH, 2019, 62 (02) : 101 - 110
  • [9] An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study
    Bora Eldem
    Timothy Y. Y. Lai
    Nor Fariza Ngah
    Brendan Vote
    Hyeong Gon Yu
    Alban Fabre
    Arthur Backer
    Nathan J. Clunas
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 963 - 973
  • [10] An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study
    Eldem, Bora
    Lai, Timothy Y. Y.
    Ngah, Nor Fariza
    Vote, Brendan
    Yu, Hyeong Gon
    Fabre, Alban
    Backer, Arthur
    Clunas, Nathan J.
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (05) : 963 - 973
12345